Ionis Pharmaceuticals (IONS) News Today: Latest Market and Industry Updates

27.39
0.4650
1.73 %
Daily range
Weekly range
  • Mira Kyivska
  • 6 hours ago
Why is Ionis Pharmaceuticals stock up 3% today?
Ionis Pharmaceuticals, Inc. (IONS) is up 3.03% today as buyers respond to ongoing momentum after the company received EU approval for its RNA-targeted therapy Tryngolza (olezarsen) to treat severe ...
  • Viktoras Karapetjanc
  • 12.10.2026
What's behind Ionis Pharmaceuticals's latest 3.3% stock pullback?
Ionis Pharmaceuticals, Inc. (IONS) dropped 3.27% today as technical momentum remained overwhelmingly negative, with clear selling pressure dominating the session. The bearish structure is ...
  • Viktoras Karapetjanc
  • 28.09.2026
What's behind Ionis Pharmaceuticals' latest stock surge?
Ionis Pharmaceuticals, Inc. (IONS) rebounded 4.21% in a sharp intraday bounce, driven by technical momentum after an extended selloff. The move looks limited, with the stock still trading below ...
  • Anastasiia Chabaniuk
  • 23.09.2026
Why is Ionis Pharmaceuticals stock down 4.7% today?
Ionis Pharmaceuticals (IONS) dropped 4.74% after investors reacted to data showing its therapy pelacarsen did not meet the primary endpoint in the HORIZON cardiovascular trial, even as positive ...
  • Ezequiel Gomes
  • 18.09.2026
Ionis Pharmaceuticals stock falls nearly 4% as heavy selling momentum and oversold signals drive price down
Ionis Pharmaceuticals, Inc. (IONS) dropped 3.93% as heavy selling momentum and oversold conditions led price action lower. The down move is supported by the persistent bearish structure, with IONS ...
  • Aleksandra Chaikina
  • 03.09.2026
What's behind Ionis Pharmaceuticals's latest 5.8% stock pullback?
Ionis Pharmaceuticals, Inc. (IONS) fell 5.77% today as persistent technical selling pressure dominated the session. The move is reinforced by the stock remaining below all key moving averages and ...
  • Parshwa Turakhiya
  • 31.07.2026
What's behind Ionis Pharmaceuticals's latest 3.5% stock pullback?
Ionis Pharmaceuticals, Inc. (IONS) fell 3.45% after reporting a second-quarter adjusted loss and disappointing clinical trial results for its lead pipeline candidate. The move is reinforced by ...
  • Parshwa Turakhiya
  • 10.07.2026
Why is Ionis Pharmaceuticals stock down 8.6% today?
Ionis Pharmaceuticals, Inc. (IONS) fell 8.6% after the company reported that its late-stage Phase 3 clinical trial for Wainua, developed with AstraZeneca, failed to reduce cardiovascular deaths ...
  • Ashutosh Sureka
  • 01.07.2026
Ionis Pharmaceuticals stock price forecast: $79.43 support in focus as IONS trades flat
Ionis Pharmaceuticals (IONS) stock is trading at $79.98 after a modest move lower on the day. Shares are slipping but remain positioned above medium- and long-term ...
  • Dan Blystone
  • 30.06.2026
Trump drug pricing push faces resistance from mid-sized pharma companies
The Trump administration is trying to expand its most-favored-nation drug pricing plan beyond the largest pharmaceutical groups through a Medicaid pilot program. The effort is meeting hesitation ...